Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory effector mechanisms in asthma

J M Drazen1, J F Evans, R L Stevens

  • 1Department of Medicine, Brigham and Women's Hospital, Merck Frost Center for Therapeutic Research, Boston, Massachusetts, USA.

American Journal of Respiratory and Critical Care Medicine
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Metric System.

Daniel's Texas medical journal·2023
Same author

A Note on the Pathology of Kala-Azar or Beri-Beri of Assam.

The Indian medical gazette·2017
Same author

A Note on the Pathology of Kala-Azar, or Beri-Beri, of Assam.

The Indian medical gazette·2017
Same author

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity.

Cellular signalling·2014
Same author

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide.

Leukemia·2012
Same author

Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2.

Journal of clinical pharmacology·2011
Same journal

When an Exacerbation Signals a Different Future in non-severe asthma.

American journal of respiratory and critical care medicine·2026
Same journal

Aim High-Stay Stable: Rethinking Treatment Success in COPD.

American journal of respiratory and critical care medicine·2026
Same journal

Three versus six weeks of corticosteroids for mild immune-related pneumonitis: a randomized trial.

American journal of respiratory and critical care medicine·2026
Same journal

Signal in the Noise: Polygenic Scores and the Problem of Defining Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same journal

Do mtDNA fragmentomic peaks reflect cancer biology or preanalytical and technical artifacts in NSCLC?

American journal of respiratory and critical care medicine·2026
Same journal

Short for Their Age: Interpreting Whole-Genome Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
See all related articles

Asthma involves multiple systems that can cause airway obstruction and alter responsiveness. These systems likely work together in asthma, and more research is needed to understand their specific roles.

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Immunology
  • Pathophysiology of Asthma

Background:

  • Asthma is a chronic respiratory disease characterized by airway inflammation and hyperresponsiveness.
  • Several effector systems contribute to the pathophysiology of asthma, including immune cells and mediators.
  • The interplay between these systems in exacerbating asthma symptoms is not fully understood.

Purpose of the Study:

  • To elucidate the roles of various effector systems in initiating airway obstruction in asthma.
  • To investigate how these effector systems influence airway responsiveness in asthmatic patients.
  • To understand the concerted action of these systems in specific asthma scenarios.

Main Methods:

  • Review of existing literature on asthma pathophysiology.

Related Experiment Videos

  • Analysis of data from preclinical asthma models.
  • Correlation of clinical observations with immunological and physiological parameters.

    • Main Results:

    • Each identified effector system possesses the capability to induce airway obstruction.
    • These systems can independently or collectively modify airway responsiveness.
    • Evidence suggests a synergistic action of these systems in particular asthma conditions.

    Conclusions:

    • Multiple effector systems are implicated in the pathogenesis of asthma.
    • These systems likely interact to drive airway obstruction and hyperresponsiveness.
    • Further investigation is crucial to delineate the precise contributions of each system and their interactions in asthma.